NANCY BUETTNER: Open Payments
NPI 1285026559 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,519 in 100 payments from 21 companies in 2025. Trend: 2023 $1,739 · 2024 $1,331 · 2025 $1,519
Food & beverage: $1,519
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $212 |
| AstraZeneca Pharmaceuticals LP | 13 | $204 |
| Amgen Inc. | 23 | $193 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $166 |
| Novartis Pharmaceuticals Corporation | 6 | $134 |
| ABBVIE INC. | 7 | $118 |
| Corcept Therapeutics | 3 | $103 |
| PFIZER INC. | 4 | $60 |
| Lilly USA, LLC | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
Products named: Kerendia, Rybelsus, OTEZLA, AIRSUPRA, LEQVIO, Korlym, UBRELVY, JARDIANCE.
Industry payments across TX — which companies pay providers there.
